Active toxoplasma chorioretinitis in immunocompromised patients: a case series

Mustafa Kayabaşı, Turhan Mammadov, Seher Köksaldı, Gül Arıkan, Süleyman Kaynak, Ali Osman Saatci


Toxoplasma chorioretinitis (TC) can exhibit atypical features in immunocompromised patients including bilaterality, extensive spread, multifocal presentation, large areas of retinal necrosis without adjacent retinal scarring, and diffuse necrotizing retinitis resembling the viral retinitis that may cause confusion in the differential diagnosis. The aim of this study was to present the clinical features of four eyes of three immunocompromised patients with active toxoplasma chorioretinitis. Two of the patients were female and one, male. Two patients had hematological malignancies and the remaining patient was under adalimumab treatment for ankylosing spondylitis. Visual complaints began 10 days to four months prior to TC diagnosis. All four eyes had mild-to-moderate anterior chamber cells together with severe vitritis on slit-lamp examination while there were solitary chorioretinitis lesions on fundoscopy. Despite all patients were negative for anti-toxoplasma immunoglobulin M, all were positive for immunoglobulin G. All three patients were successfully treated with a combined treatment of systemic and intravitreal anti-toxoplasmic drugs. Clinicians should be cautious for the possible toxoplasma chorioretinitis besides the other infectious entities when a new uveitis episode is detected in an immunosuppressed patient in order to avoid misdiagnosis and thereby wrong treatment.


Anti-toxoplasmic therapy; immunosuppression; ocular toxoplasmosis; toxoplasma chorioretinitis; uveitis

Full Text:



Biancardi AL, Costa JB, de Azevedo LGB, et al. Severe Necrotising Toxoplasmic Retinochoroiditis in a Patient With Crohn's Disease in Use of Adalimumab and Azathioprine. Inflamm Bowel Dis. 2020 Jun 18;26(7):e69-e70. doi: 10.1093/ibd/izaa105. PMID: 32415301.

Javadzadeh S, Gkini MA, Panos GD, Adewoyin T, Bewley A. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis. Clin Exp Dermatol. 2020 Aug;45(6):802-804. doi: 10.1111/ced.14198. Epub 2020 Mar 25. PMID: 32212270.

Rodrigues KF, Faria e Arantes TE, Muccioli C, Neto JL, Pinheiro MM. Incidence of Toxoplasma retinochoroiditis in patients with ankylosing spondylitis after using TNF-α blockers. Parasitol Int. 2013 Jun;62(3):272-5. doi: 10.1016/j.parint.2013.02.003. PMID: 23485566.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification Criteria for Toxoplasmic Retinitis. Am J Ophthalmol. 2021 Aug;228:134-141. doi: 10.1016/j.ajo.2021.03.042. PMID: 33845002; PMCID: PMC8594742.

Xu K, Hao Y. Determination of the density of human nuclear cataract lenses. Mol Med Rep. 2013 Nov;8(5):1300-4. doi: 10.3892/mmr.2013.1673. PMID: 24026512; PMCID: PMC3820609.

Davis JL, Madow B, Cornett J, et al. Scale for photographic grading of vitreous haze in uveitis. Am J Ophthalmol. 2010 Nov;150(5):637-641.e1. doi: 10.1016/j.ajo.2010.05.036. PMID: 20719302; PMCID: PMC3220938.

Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-16. doi: 10.1016/j.ajo.2005.03.057. PMID: 16196117; PMCID: PMC8935739.

Smith JR, Cunningham ET Jr. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol. 2002 Dec;13(6):387-92. doi: 10.1097/00055735-200212000-00008. PMID: 12441842.

Fardeau C, Romand S, Rao NA, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 2002 Aug;134(2):196-203. doi: 10.1016/s0002-9394(02)01500-3. PMID: 12140026.

Figueroa-Vercellino JP, Miguel L, Moll-Udina A, et al. Atypical toxoplasmic retinochoroiditis in patients with malignant hematological diseases. Arch Soc Esp Oftalmol (Engl Ed). 2021 Mar;96(3):152-156. English, Spanish. doi: 10.1016/j.oftal.2020.05.032. PMID: 32651033.

Theodoropoulou S, Schmoll C, Templeton K, Dhillon B. Atypical toxoplasmic retinochoroiditis. BMJ Case Rep. 2012 May 30;2012:bcr1220115419. doi: 10.1136/bcr.12.2011.5419. PMID: 22669878; PMCID: PMC4543018.

Lassoued S, Zabraniecki L, Marin F, Billey T. Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum. 2007 Feb;36(4):262-3. doi: 10.1016/j.semarthrit.2006.08.004. PMID: 17067660.

Holland GN, Engstrom RE Jr, Glasgow BJ, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988 Dec 15;106(6):653-67. doi: 10.1016/0002-9394(88)90697-6. PMID: 3195645.

Elkins BS, Holland GN, Opremcak EM, et al. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994 Mar;101(3):499-507. doi: 10.1016/s0161-6420(13)31267-6. PMID: 8127570.

Conrath J, Mouly-Bandini A, Collart F, Ridings B. Toxoplasma gondii retinochoroiditis after cardiac transplantation. Graefes Arch Clin Exp Ophthalmol. 2003 Apr;241(4):334-8. doi: 10.1007/s00417-003-0647-3. PMID: 12719997.

Garg A, McKay BR, Francisconi CLM, Muni RH. Toxoplasmosis chorioretinitis mimicking cytomegalovirus retinitis in an immunocompromised pediatric patient following bone marrow transplantation. GMS Ophthalmol Cases. 2022 Jun 7;12:Doc14. doi: 10.3205/oc000201. PMID: 35912126; PMCID: PMC9284721.

Galván Ramírez ML, Castillo-de-León Y, Espinoza-Oliva M, et al. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant. Transpl Infect Dis. 2006 Dec;8(4):233-6. doi: 10.1111/j.1399-3062.2006.00140.x. PMID: 17116139.

Walkden A, Wig S, Bhatt PR, Jones NP, Steeples LR. Atypical Ocular Toxoplasmosis During Adalimumab Anti-Tumor Necrosis Factor Therapy for Rheumatoid Arthritis. J Clin Rheumatol. 2020 Dec;26(8):e279-e280. doi: 10.1097/RHU.0000000000001124. PMID: 31295158.

Crosson JN, Kuthyar S, Shantha JG, et al. Toxoplasmosis chorioretinitis mimicking acute retinal necrosis associated with local corticosteroid. Int J Retina Vitreous. 2020 Jun 3;6:21. doi: 10.1186/s40942-020-00225-0. PMID: 32514378; PMCID: PMC7268411.

Oray M, Ozdal PC, Cebeci Z, Kir N, Tugal-Tutkun I. Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy. Ocul Immunol Inflamm. 2016 Dec;24(6):637-646. doi: 10.3109/09273948.2015.1057599. PMID: 26647176.

Wong R, dell'Omo R, Marino M, et al. Toxoplasma gondii: an atypical presentation of toxoplasma as optic disc swelling and hemispherical retinal vein occlusion treated with intravitreal clindamycin. Int Ophthalmol. 2009 Jun;29(3):195-8. doi: 10.1007/s10792-008-9192-8. PMID: 18297246.

Kim SJ, Scott IU, Brown GC, et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013 Feb;120(2):371-8. doi: 10.1016/j.ophtha.2012.07.061. PMID: 23062648.

Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers. 2001 May-Jun;32(3):183-92. PMID: 11371084.

Hedayatfar A, Zand A, Faghihi H, Gordiz A, Abdi F. Macular Infarction following Intravitreal Clindamycin Injection : A Case Report. J Curr Ophthalmol. 2021 Oct 22;33(3):349-353. doi: 10.4103/joco.joco_150_20. PMID: 34765827; PMCID: PMC8579790.


Copyright (c) 2024 Mustafa Kayabaşı, Turhan Mammadov, Seher Köksaldı, Gül Arıkan, Süleyman Kaynak, Ali Osman Saatci

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975